Keywords: CoDa Therapeutics, RusNano, Financing, Russia, Nexagon, Diabetic foot ulcers, Licensing

CoDa Therapeutics gets Russian investment boost

Article | 30 July 2012

Print This

San Diego, USA-based CoDa Therapeutics says that it raised an additional $20 million from RusnanoMedInvest (RMI), a subsidiary of Russia’ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in